A Randomized Controlled Trial of Balloon Dilation as a Treatment for Persistent Eustachian Tube Dysfunction With 1-Year Follow-Up
| العنوان: | A Randomized Controlled Trial of Balloon Dilation as a Treatment for Persistent Eustachian Tube Dysfunction With 1-Year Follow-Up |
|---|---|
| المؤلفون: | Jason Cai, Ted A. Meyer, Christopher F. D’esposito, Jeffrey L. Cutler, Habib G. Rizk, Zachary M. Soler, Roger J. Simpson, Michael J. Clark, Patrick W. Slater, Rodney J. Schlosser, Theodore R. McRackan, Mark J. Hoy, Ellen M O'Malley, Shaun A. Nguyen |
| المصدر: | Otology & Neurotology |
| بيانات النشر: | Ovid Technologies (Wolters Kluwer Health), 2018. |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | Randomized control trial, Adult, Male, medicine.medical_specialty, Eustachian tube, 1 year follow up, Prosthetic Devices, Tertiary care, law.invention, 03 medical and health sciences, 0302 clinical medicine, Patient satisfaction, In-office procedures, Randomized controlled trial, law, otorhinolaryngologic diseases, medicine, Humans, Prospective Studies, Ear Diseases, 030223 otorhinolaryngology, Prospective cohort study, Aged, 7-item Eustachian tube dysfunction questionnaire, business.industry, Eustachian Tube, Hearing Tests, Middle Aged, Eustachian tube dysfunction, Dilatation, Sensory Systems, Surgery, Treatment Outcome, medicine.anatomical_structure, Otorhinolaryngology, Patient Satisfaction, Patient-reported outcome measures, 030220 oncology & carcinogenesis, Balloon dilation, Female, Neurology (clinical), business, Follow-Up Studies |
| الوصف: | Objective: Compare Eustachian tube balloon dilation versus continued medical therapy (control) for treating persistent Eustachian tube dysfunction (ETD). Study Design: Prospective, multicenter, randomized controlled trial. Setting: Tertiary care academic center and private practice. Patients: Diagnosed with medically refractory persistent ETD. Interventions: 1:1 Randomization to balloon dilation or control. After 6 weeks, control participants had the option to undergo balloon dilation if symptoms persisted. Main Outcome Measures: Primary efficacy endpoint was the comparison between treatment arms in the mean change from baseline in the 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) score. Primary safety endpoint was complication rate. Results: Sixty participants were randomized (31 balloon dilation, 29 control). Mean (SD) change in overall ETDQ-7 score at 6 weeks was −2.9 (1.4) for balloon dilation compared with −0.6 (1.0) for control: balloon dilation was superior to control (p |
| تدمد: | 1537-4505 1531-7129 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0da539b0906306f08a98cf555e022a7Test https://doi.org/10.1097/mao.0000000000001853Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....a0da539b0906306f08a98cf555e022a7 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15374505 15317129 |
|---|